These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Quantitative and qualitative differences between benign and malignant mesothelial cells in pleural fluid. Kwee WS; Veldhuizen RW; Alons CA; Morawetz F; Boon ME Acta Cytol; 1982; 26(4):401-6. PubMed ID: 6957089 [TBL] [Abstract][Full Text] [Related]
7. The cytology of malignant mesothelioma in Western Australia. Whitaker D; Shilkin KB Acta Cytol; 1978; 22(2):67-70. PubMed ID: 276234 [TBL] [Abstract][Full Text] [Related]
8. Role of computerized morphometric analysis in diagnosis of effusion specimens. Arora B; Setia S; Rekhi B Diagn Cytopathol; 2006 Oct; 34(10):670-5. PubMed ID: 16955473 [TBL] [Abstract][Full Text] [Related]
9. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology. Granados R; Cibas ES; Fletcher JA Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903 [TBL] [Abstract][Full Text] [Related]
10. Quantitative light microscopy of atypical mesothelial cells and malignant cells in ascitic fluid. van de Molengraft FJ; van 't Hof MA; Herman CJ; Vooijs PG Anal Quant Cytol; 1982 Sep; 4(3):217-20. PubMed ID: 7149486 [TBL] [Abstract][Full Text] [Related]
11. The cytologic diagnosis of mesothelioma. Ehya H Semin Diagn Pathol; 1986 Aug; 3(3):196-203. PubMed ID: 3616223 [TBL] [Abstract][Full Text] [Related]
12. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis. Cakir E; Demirag F; Aydin M; Unsal E Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123 [TBL] [Abstract][Full Text] [Related]
13. [Comparing electron microscopical investigation of cells from mesotheliomas (author's transl)]. Jaugitz H Arch Geschwulstforsch; 1977; 47(3):204-9. PubMed ID: 907441 [TBL] [Abstract][Full Text] [Related]
14. Cytopathology of serous neoplasia of the ovary and the peritoneum: differential diagnosis from mesothelial proliferations. Pisharodi LR; Bedrossian CW Diagn Cytopathol; 1996 Nov; 15(4):292-5. PubMed ID: 8982583 [TBL] [Abstract][Full Text] [Related]
15. [Mesothelioma of the pleura: cytology, coagulation of protein (Weltmann) and hyaluronic acid as parameters of clinical diagnosis (author's transl)]. Matzel W Z Erkr Atmungsorgane; 1980; 155(1):133-9. PubMed ID: 7210738 [TBL] [Abstract][Full Text] [Related]
16. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma. Ylagan LR; Zhai J Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333 [TBL] [Abstract][Full Text] [Related]
17. Digital image analysis in cytological diagnosis: a morphometric analysis on pleural mesotheliomas. Christen H; Oberholzer M; Buser M; Lötscher R; Gschwind R; Rösel F; Ettlin R; Feess A; Dalquen P Anal Cell Pathol; 1989 Apr; 1(2):105-22. PubMed ID: 2487514 [TBL] [Abstract][Full Text] [Related]
18. Cell aggregates in malignant mesothelioma. Whitaker D Acta Cytol; 1977; 21(2):236-9. PubMed ID: 266334 [TBL] [Abstract][Full Text] [Related]
19. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Friedman MT; Gentile P; Tarectecan A; Fuchs A Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609 [TBL] [Abstract][Full Text] [Related]
20. Benign and malignant mesothelial proliferations. Koss LG Am J Surg Pathol; 2001 Apr; 25(4):548-9. PubMed ID: 11257637 [No Abstract] [Full Text] [Related] [Next] [New Search]